Journal articleClin Cancer Res2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer.
- Journal
- Clin Cancer Res
- Published
- 30 September 2021
- Citations
- 47
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510↗
- The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic Cancer R01CA177670↗
- Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy R01CA244938↗
- Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity R01CA248917↗
- Re-wiring PDAC Tumor Immunity Through Dendritic Cells R01CA262506↗